Top Page
THG
(LSE:THG)
THG (THG) vs. iShares MSCI United Kingdom ETF (EWC)
THG Business Overview & Revenue Model
THG Earnings Call Summary
THG Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.60B | 1.75B | 2.05B | 2.24B | 2.18B | 1.61B |
| Gross Profit | 659.89M | 693.60M | 840.29M | 771.00M | 855.37M | 655.91M |
| EBITDA | -48.37M | -48.64M | 42.42M | -289.44M | 32.07M | -376.33M |
| Net Income | -128.64M | -326.14M | -248.37M | -539.96M | -138.07M | -532.63M |
Balance Sheet | ||||||
| Total Assets | 1.62B | 2.55B | 2.78B | 3.09B | 3.42B | 2.45B |
| Cash, Cash Equivalents and Short-Term Investments | 129.41M | 309.35M | 416.16M | 473.78M | 536.83M | 773.58M |
| Total Debt | 601.39M | 645.94M | 995.01M | 1.01B | 839.04M | 762.34M |
| Total Liabilities | 1.20B | 2.24B | 1.76B | 1.79B | 1.67B | 1.30B |
| Stockholders Equity | 424.12M | 305.83M | 1.02B | 1.30B | 1.76B | 1.14B |
Cash Flow | ||||||
| Free Cash Flow | 53.16M | 28.99M | 16.15M | -164.27M | -190.88M | -198.98M |
| Operating Cash Flow | 70.53M | 96.46M | 141.81M | 12.15M | -1.71M | 40.39M |
| Investing Cash Flow | -57.14M | -92.11M | -77.14M | -182.11M | -959.06M | -351.32M |
| Financing Cash Flow | -66.40M | -22.91M | -122.29M | 106.92M | 724.01M | 772.28M |
THG Technical Analysis
THG Risk Analysis
THG Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £350.89M | 8.09 | 13.18% | 3.61% | 6.18% | 4.22% | |
63 Neutral | £577.26M | 55.74 | 6.87% | ― | 9.45% | -57.24% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £700.25M | -4.54 | -18.75% | ― | -20.36% | 44.33% | |
47 Neutral | £668.98M | -70.37 | ― | 1.46% | 2.62% | -129.82% | |
46 Neutral | £274.50M | -0.93 | -62.59% | ― | -15.86% | -18.46% | |
38 Underperform | £154.49M | -0.46 | -185.68% | ― | -45.91% | -120.22% |
THG Corporate Events
THG PLC reported its strongest quarter of organic sales growth since 2021, with a 6.3% increase in Q3 revenue, driven by significant growth in both THG Beauty and THG Nutrition. The company has returned to year-to-date revenue growth, aided by strategic changes and brand investments. Despite the impact of asset disposals and discontinued activities, THG Beauty achieved a 4.2% revenue growth, bolstered by a successful advent launch and strong UK retail momentum. THG Nutrition reported a 10.0% YoY growth, the highest in over two years, with expansion in the US and Middle East markets. The company remains optimistic about meeting its full-year performance expectations, entering its most profitable period.
The most recent analyst rating on (GB:THG) stock is a Hold with a £0.43 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC reported its strongest quarter of organic sales growth since 2021, with a 6.3% increase in Q3 revenue, driven by significant growth in THG Nutrition and continued momentum in THG Beauty. Despite the impact of asset disposals and discontinued activities, the company returned to year-to-date revenue growth, positioning itself favorably against its revenue guidance for the second half of 2025. THG Beauty experienced a notable advent sales contribution and growth in UK retail, while THG Nutrition saw its highest revenue growth rate in over two years, supported by online and offline channel expansion and strategic partnerships. The company’s strategic initiatives and operational changes have set a strong foundation for the upcoming key trading period.
The most recent analyst rating on (GB:THG) stock is a Hold with a £0.43 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
In the latest earnings call, THG Plc presented a balanced outlook with notable strategic achievements alongside some persistent challenges. The company highlighted positive developments such as growth in the THG Nutrition division, strengthening of the balance sheet, and successful disposals. However, it also acknowledged challenges like a decline in group revenue and high input costs in the Nutrition segment. Overall, the sentiment was balanced, reflecting both optimism and caution.
THG PLC reported its interim results for the first half of 2025, showing a return to revenue growth in the second quarter, driven by strategic changes in its beauty and nutrition divisions. The company completed a successful demerger of THG Ingenuity and disposed of Claremont Ingredients, which, along with refinancing, improved its net cash position. Despite a slight decline in overall group revenue, THG anticipates stronger performance in the second half, supported by increased brand partnerships and market share gains, particularly in the UK beauty sector and Myprotein’s expansion in offline retail and licensing.
The most recent analyst rating on (GB:THG) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC announced that it will release its interim results for the six months ending 30 June 2025 on 11 September 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor confidence.
The most recent analyst rating on (GB:THG) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC has announced that Sue Farr, currently serving as the Senior Independent Director, will be joining Vistry Group PLC as a non-executive director starting from October 1, 2025. This move signifies a strategic alignment and potential collaboration between the two companies, which could influence THG’s market positioning and stakeholder relations.
The most recent analyst rating on (GB:THG) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC has announced the sale of Claremont Ingredients, a UK-based flavour manufacturing and development laboratory, to Nactarome Group for approximately £103 million. This move aligns with THG’s strategy to simplify its operations and achieve a net cash balance sheet. The sale represents a significant return on investment, as Claremont was originally acquired for £52 million in 2020. Financially, the disposal will aid in reducing THG’s net leverage and borrowing costs. Operationally, the relationship with Claremont will continue through a long-term supply contract, ensuring Myprotein’s flavour capabilities remain robust. The transaction is expected to impact THG’s EBITDA in the coming years, but the company anticipates double-digit revenue growth for THG Nutrition in the second half of 2025, driven by stable whey prices and strategic pricing approaches to enhance market share.
The most recent analyst rating on (GB:THG) stock is a Sell with a £0.49 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.
THG PLC has announced the sale of Claremont Ingredients, a UK-based flavour manufacturing and development laboratory, to Nactarome Group for approximately £103 million. This divestment aligns with THG’s strategy to simplify its operations and achieve a net cash balance sheet. The sale represents a significant return on investment, as Claremont was acquired for £52 million in 2020. Financially, the disposal will help reduce THG’s net leverage and borrowing costs, although it is expected to decrease the Group’s EBITDA for FY 2025 and FY 2026 by £5 million and £10 million, respectively. The strategic move is part of THG’s broader plan to focus on core strengths and market share growth, particularly for its Myprotein brand, which is expected to see double-digit revenue growth in the second half of 2025.
The most recent analyst rating on (GB:THG) stock is a Sell with a £0.49 price target. To see the full list of analyst forecasts on THG stock, see the GB:THG Stock Forecast page.